Literature DB >> 25289497

Cross-reactions of anti-DNA antibodies and the central dogma of lupus nephritis.

D Eilat1.   

Abstract

DNA-anti-DNA immune complexes have been implicated in the path1ogenesis of systemic lupus erythematosus (SLE) despite the absence of convincing evidence for the presence of DNA antigen in patients' blood or tissues. Several cross-reactions of anti-DNA antibodies have been described in recentyears. Some of these reactions provide new insights into the mechanisms of tissue injury in SLE. Here Dan Eilat suggests that the target antigen for anti-DNA antibodies may be other than DNA.
Copyright © 1985. Published by Elsevier B.V.

Entities:  

Year:  1985        PMID: 25289497     DOI: 10.1016/0167-5699(85)90077-5

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  12 in total

Review 1.  The role of anti-DNA antibodies in lupus nephritis.

Authors:  M Waer
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

2.  Inhibiting effect of charged polymers on interaction of human lupus autoantibodies with certain intracellular proteins.

Authors:  A E Kabakov; L N Brovkina; A M Poverenny; L Cebecauer
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

Review 3.  The anti-DNA antibody: origin and impact, dogmas and controversies.

Authors:  Ole P Rekvig
Journal:  Nat Rev Rheumatol       Date:  2015-06-02       Impact factor: 20.543

Review 4.  Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus.

Authors:  A J Swaak; V Huysen; J C Nossent; R J Smeenk
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 5.  Antibodies to DNA in patients with systemic lupus erythematosus. Their role in the diagnosis, the follow-up and the pathogenesis of the disease.

Authors:  R Smeenk; K Brinkman; H van den Brink; R M Termaat; J Berden; H Nossent; T Swaak
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

6.  Analysis of autoantibody specificities in selected systemic lupus erythematosus (SLE) sera.

Authors:  A M Francoeur
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

7.  Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients.

Authors:  K Pirner; A Rascu; W Nürnberg; A Rubbert; J R Kalden; B Manger
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

8.  Anti-DNA antibodies of IgA class in patients with systemic lupus erythematosus.

Authors:  M Gripenberg; T Helve
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

Review 9.  Anti-dsDNA: choice of assay in relation to clinical value.

Authors:  R J Smeenk; H G van den Brink; K Brinkman; R M Termaat; J H Berden; A J Swaak
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

10.  Electric charge and sugar chains of immunoglobulin G in systemic lupus erythematosus.

Authors:  Koji Kinoshita; Sinya Ikoma; Toshiaki Yamagata; Yuji Nozaki; Masafumi Sugiyama; Masanori Funauchi
Journal:  Clin Exp Nephrol       Date:  2006-03       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.